Science & Technology
Development of a Highly Specific and Sensitive HSV-1 and HSV-2 Diagnostic Test
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43AI176913-01
Award Ceiling
$291K
Award Floor
$291K
Close Date
May 31, 2024
Total Funding
$291K
Expected Awards
1
Posted Date
Aug 1, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R43AI176913-01
Description
SBIR Phase Phase I award: "Development of a Highly Specific and Sensitive HSV-1 and HSV-2 Diagnostic Test" awarded to RATIONAL VACCINES INC in Baton Rouge, Louisiana. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $291,480. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.